Before you sell to, join or invest in Tasca Therapeutics Corp
MentionFox check on Tasca Therapeutics Corp: only 2 sources on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/tasca-therapeutics-corp-form-d-24000001
Check Tasca Therapeutics Corp before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Tasca Therapeutics Corp filed an amended Form D with the Securities and Exchange Commission on 2024-11-29.
Tasca Therapeutics Corp filed an amended Form D notice of an exempt securities offering with the SEC on November 29, 2024. The filing reports $48.10M sold. Its industry group is Biotechnology. It names Milenko Cicmil (Executive Officer, Director), Drew King (Executive Officer), Xu Wu (Director) (SEC Form D/A, November 29, 2024).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Tasca Therapeutics Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-11-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Tasca Therapeutics Corp.
Free to see. No signup.
Get an email when Tasca Therapeutics Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Tasca Therapeutics Corp raises, hires or launches. No email unless you switch it on.
Watch Tasca Therapeutics Corp →Get the full cited report on Tasca Therapeutics Corp
What the filing shows about Tasca Therapeutics Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Tasca Therapeutics Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Tasca Therapeutics Corp's address as 55 Spinelli Place, Cambridge, MA 02138.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-12-01: the amount sold changed from $24,149,994 to $48,099,985; the number of investors changed from 7 to 9. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Tasca Therapeutics Corp See pricing
Tasca Therapeutics Corp is a registered filer with the SEC (CIK 2046762) and has filed since 2024-11-29. 2 filings are on record, the latest on 2025-12-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Tasca Therapeutics Corp's Form D of 2024-11-29 names Milenko Cicmil, Drew King, Xu Wu and 4 more as its officers, directors or promoters.
Its new offerings report $24.15M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
The proceeds are available to fund general working capital requirements; as of the date of this filing, no detailed operating budget has been adopted; and no proceeds have been or are proposed to be used for payments of finders fees or other compensation.
Milenko Cicmil is named as Executive Officer and Director on the Form D that Tasca Therapeutics Corp filed with the SEC on 29 November 2024, one of 7 people that filing names.
Drew King is named as Executive Officer on the Form D that Tasca Therapeutics Corp filed with the SEC on 29 November 2024, one of 7 people that filing names.
Xu Wu is named as Director on the Form D that Tasca Therapeutics Corp filed with the SEC on 29 November 2024, one of 7 people that filing names.
David Fallace is named as Director on the Form D that Tasca Therapeutics Corp filed with the SEC on 29 November 2024, one of 7 people that filing names.
Michael Aberman is named as Director on the Form D that Tasca Therapeutics Corp filed with the SEC on 29 November 2024, one of 7 people that filing names.
Praveen Tipirneni is named as Director on the Form D that Tasca Therapeutics Corp filed with the SEC on 29 November 2024, one of 7 people that filing names.
Seth Lieblich is named as Director on the Form D that Tasca Therapeutics Corp filed with the SEC on 29 November 2024, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2024-11-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Tasca Therapeutics Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Tasca Therapeutics Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Tasca Therapeutics Corp covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Tasca Therapeutics CorpYou get an alert in MentionFox the next time this company shows up.
If you're behind Tasca Therapeutics Corp: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Tasca Therapeutics Corp. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/tasca-therapeutics-corp-form-d-24000001